Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2008-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms
NCT06078930
Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients
NCT05721963
The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study
NCT06220630
AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data
NCT06957678
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
NCT03257735
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To study the current diagnosis and treatment of gallbladder cancer in China.
2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer.
3. To improve the accurate staging of gallbladder cancer.
4. To standardize the treatment with gallbladder cancer.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with accessible electronic medical record
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital of Anhui Medical University
OTHER
Anhui Provincial Hospital
OTHER_GOV
The First Affiliated Hospital of Bengbu Medical University
OTHER
LanZhou University
OTHER
Henan Cancer Hospital
OTHER_GOV
The First Affiliated Hospital of Zhengzhou University
OTHER
The Second Affiliated Hospital of Harbin Medical University
OTHER
First Affiliated Hospital of Harbin Medical University
OTHER
Harbin Medical University
OTHER
The First Hospital of Jilin University
OTHER
Second Hospital of Jilin University
OTHER
China-Japan Union Hospital, Jilin University
OTHER
The First People's Hospital of Changzhou
OTHER
Changzhou No.2 People's Hospital
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
OTHER
The First People's Hospital of Taicang
UNKNOWN
Wuxi No. 2 People's Hospital
OTHER
Xuzhou Central Hospital
OTHER
Second Affiliated Hospital of Suzhou University
OTHER
Affiliated Hospital of Nantong University
OTHER
The First People's Hospital of Nantong
UNKNOWN
The Affiliated Hospital of Xuzhou Medical University
OTHER
Second Affiliated Hospital of Nanchang University
OTHER
The First Affiliated Hospital of Nanchang University
OTHER
Jiangxi Provincial People's Hopital
OTHER
Shengjing Hospital
OTHER
Baotou Central Hospital
OTHER
Qinghai People's Hospital
OTHER
Changzhi Medical College
OTHER
The First Affiliated Hospital of Shanxi Medical University
OTHER
Shaanxi Provincial Cancer Hospital
OTHER
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Eastern Hepatobiliary Surgery Hospital
OTHER
Shanghai Fengxian District Central Hospital
OTHER
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Shanghai Zhongshan Hospital
OTHER
Shanghai Pudong Hospital
OTHER
Central Hospital of Minhang District, Shanghai
UNKNOWN
Putuo District People's Hospital of Shanghai
UNKNOWN
Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
UNKNOWN
Tianjin Medical University Cancer Hospital
UNKNOWN
First Affiliated Hospital of Xinjiang Medical University
OTHER
First Affiliated Hospital of Kunming Medical University
OTHER
Yinzhou Hospital Affiliated to Medical School of Ningbo University
OTHER
Shaoxing Second Hospital
OTHER
Shaoxing People's Hospital
OTHER
First Affiliated Hospital of Wenzhou Medical University
OTHER
Sir Run Run Shaw Hospital
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Zhejiang Cancer Hospital
OTHER
Huizhou Municipal Central Hospital
OTHER
Ningbo No. 1 Hospital
OTHER
People's Hospital of Hunan Province
UNKNOWN
Hainan People's Hospital
OTHER
Taizhou Hospital
OTHER
Xinghua City People's Hospital
UNKNOWN
Tongliao City Hospital
UNKNOWN
Jiangxi Provincial Cancer Hospital
OTHER
Shandong Provincial Hospital
OTHER_GOV
Qilu Hospital of Shandong University
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Xijing Hospital
OTHER
Shanghai Jiao Tong University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yingbin Liu, MD, PhD, FACS
Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yingbin Liu, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China
Anhui Provincial Hospital
Hefei, Anhui, China
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
The First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Henan Cancer Hospital
Zhengzhou, Henan, China
The Fifth Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
People's Hospital of Hunan Province
Changsha, Hunan, China
Baotou City Central Hospital
Baotou, Inner Mongolia, China
Changshu No.1 People's Hospital
Changshu, Jiangsu, China
Changzhou No.2 People's Hospital
Changzhou, Jiangsu, China
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
The First People's Hospital of Nantong
Nantong, Jiangsu, China
Affiliated Hospital of Nantong University
Nantong, Jiangsu, China
Nantong Tumor Hospital
Nantong, Jiangsu, China
The Second Affiliated Hospital of Suzhou University
Suzhou, Jiangsu, China
The First People's Hospital of Taicang
Taicang, Jiangsu, China
Wuxi Second People's Hospital
Wuxi, Jiangsu, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Xuzhou Central Hospital
Xuzhou, Jiangsu, China
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The First Bethune Hospital of Jilin University
Changchun, Jilin, China
China-Japan Union Hospital of Jilin University
Changchun, Jilin, China
The Second Hospital of Jilin University
Changchun, Jilin, China
The First Hospital of Lanzhou University
Gansu, Lanzhou, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Qinghai Provincial People's Hospital
Xining, Qinghai, China
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Zhongshan Hospital
Shanghai, Shanghai Municipality, China
Putuo District People's Hospital of Shanghai
Shanghai, Shanghai Municipality, China
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Xinhua Hospital
Shanghai, Shanghai Municipality, China
Eastern Hepatobiliary Surgery Hospital
Shanghai, Shanghai Municipality, China
Central Hospital of Minhang District
Shanghai, Shanghai Municipality, China
Shanghai Pudong Hospital
Shanghai, Shanghai Municipality, China
Shanghai Fengxian District Central Hospital
Shanghai, Shanghai Municipality, China
Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, China
First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, China
Tianjin Medical University Cancer Hospital
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
The Second Affiliated Hospital of Zhejiang University School of medicine
Hangzhou, Zhejiang, China
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Huzhou Central Hospital
Huzhou, Zhejiang, China
Ningbo First Hospital
Ningbo, Zhejiang, China
Yinzhou Hospital Affiliated to Medical School of Ningbo University
Ningbo, Zhejiang, China
Shaoxing People's Hospital
Shaoxing, Zhejiang, China
Shaoxing Second Hospital
Shaoxing, Zhejiang, China
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jianguang Jia, MD
Role: primary
Lianxin Liu, MD
Role: primary
Yeben Qian, MD
Role: primary
Bei Sun, MD
Role: primary
Bing Li, 150081
Role: primary
Yunfu Cui, MD
Role: primary
Yawei Hua, MD
Role: primary
Xiaoyong Li, MD
Role: primary
Changjun Liu, MD
Role: primary
Mingzhang Li, MD
Role: primary
Jianfeng Gu, MD
Role: primary
Chunfu Zhu, MD
Role: primary
Yudong Qiu, MD
Role: primary
Hong Zang, MD
Role: primary
Peng Wang, MD
Role: primary
Hongyu Cai, MD
Role: primary
Xiaoming Ma, MD
Role: primary
Yi Wang, MD
Role: primary
Lei Wang, MD
Role: primary
Jian Hong, MD
Role: primary
Yuzhen Xu, MD
Role: primary
Xiaoliang Chen, MD
Role: primary
Lu Fang, MD
Role: primary
Linhui Zheng, MD
Role: primary
Yajun Geng, MD
Role: primary
Hong Cao, MD
Role: primary
Xuewen Zhang, MD
Role: primary
Xun Li, MD
Role: primary
Chaoliu Dai, MD
Role: primary
Haihong Zhu, MD
Role: primary
Chang Liu, MD
Role: primary
Houbao Liu, MD
Role: primary
Jiahua Yang, MD
Role: primary
Junmin Xu, MD
Role: primary
Xiaoqing Jiang
Role: primary
Longhua Rao, MD
Role: primary
Xiaoping Yang, MD
Role: primary
Xueli Zhang, MD
Role: primary
Zhewei Fei, MD
Role: primary
Buqiang Wu, MD
Role: primary
Jiansheng Liu, MD
Role: primary
Xueyi Dang, MD
Role: primary
Jihui Hao, MD
Role: primary
Wei Han, MD
Role: primary
Kunhua Wang, MD
Role: primary
Jinhui Zhu, MD
Role: primary
Defei Hong, MD
Role: primary
Xinbao Wang, MD
Role: primary
Weilong Cai, MD
Role: primary
Zhiping Zhang, MD
Role: primary
Kejun Hua, MD
Role: primary
Feng Tao, MD
Role: primary
Zaiyang Zhang, MD
Role: primary
Mengtao Zhou, MD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Li L, Ren T, Liu K, Li ML, Geng YJ, Yang Y, Li HF, Li XC, Bao RF, Shu YJ, Weng H, Gong W, Lau WY, Wu XS, Liu YB. Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit. Front Oncol. 2021 Jun 29;11:692647. doi: 10.3389/fonc.2021.692647. eCollection 2021.
Ren T, Li Y, Zhang X, Geng Y, Shao Z, Li M, Wu X, Wang XA, Liu F, Wu W, Shu Y, Bao R, Gong W, Dong P, Dang X, Liu C, Liu C, Sun B, Liu J, Wang L, Hong D, Qin R, Jiang X, Zhang X, Xu J, Jia J, Yang B, Li B, Dai C, Cao J, Cao H, Tao F, Zhang Z, Wang Y, Jin H, Cai H, Fei Z, Gu J, Han W, Feng X, Fang L, Zheng L, Zhu C, Wang K, Zhang X, Li X, Jin C, Qian Y, Cui Y, Xu Y, Wang X, Liu H, Hua Y, Liu C, Hao J, Wang C, Li Q, Li X, Liu J, Li M, Qiu Y, Wu B, Zheng J, Chen X, Zhu H, Hua K, Yan M, Wang P, Zang H, Ma X, Hong J, Liu Y. Protocol for a gallbladder cancer registry study in China: the Chinese Research Group of Gallbladder Cancer (CRGGC) study. BMJ Open. 2021 Feb 16;11(2):e038634. doi: 10.1136/bmjopen-2020-038634.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRGGC_LYB_2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.